Healius Share Price and Company Fundamentals



Price
$3.03
Change
0.110 (3.767%)
52 week
2.78 - 5.54

Last traded: Last Friday at 5:10 AM

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Key Metrics

PE ratio

5.86

PB ratio

0.88

Dividend yield

5.48%

Beta

1.09

Market cap

-

Enterprise value

-

Company profile

Primary activities Service company for medical, para-medical and related services, and day surgery operator.
Industry / Sector Diagnostics & Research / Healthcare
Full time employees 11000
Website https://www.healius.com.au
Mailing address Liberty Place Level 22 161 Castlereagh Street Sydney NSW 2000 Australia
Phone / Fax 61 2 9432 9400 / 61 2 9432 9447
Share registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

More: Healius Dividend history, yield and payout ratio

Dividend yield

5.48%

Dividend amount

$0.16

Payout ratio

33.72%

5Y Avg. yield

2.79%

Healius paid $0.16 dividend and the ex-dividend date was 07 Sept 2022.The dividend payout ratio is 33.72%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.HLS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

HLS's forward dividend amount is $0.12 and the forward dividend yield is 4.12%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Dec 2022, following are the company executives and directors listed on Healius.

Name Title Age Total Pay
Dr. Malcolm W. Parmenter B.S., M.A.I.C.D., M.S. MD, CEO & Director 66 2.61M
Ms. Maxine Jaquet CFO & COO 1.44M
Mr. John McKechnie Chief Exec. of the Pathology Division 1.09M
Mr. Rob Phipps Group Exec. of People & Culture and Sustainability
Mr. Henry Barclay Chief Exec. of Day Hospitals
Mr. Charles Tilley B.Sc., FCIS, L.L.B., B.Sc. (Hons), LLB (Hons) Company Sec.
Ms. Alison Stephenson Additional Company Sec.
Ms. Janet Payne Group Exec. of Corp. Affairs
Dr. John Houston Advisor

Profitability and management effectiveness

Profit margin

13.18%

Operating margin

20.90%

Return on assets

7.71%

Return on equity

15.56%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Healius is and its enterprise value is .

The HLS's stocks Beta value is 1.09 making it 9% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Healius (HLS)

Healius (ASX:HLS) Frequently Asked Questions

1. What is Healius's Stock Symbol?

Healius trades on ASX under the ticker symbol "HLS".

2. What is Healius's stock price today?

One share of HLS stock can currently be purchased for approximately $3.03.

3. How can I contact Healius?

Healius's mailing address is Liberty Place Level 22 161 Castlereagh Street Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9432 9400.

4. What is Healius's official website?

The official website of Healius is https://www.healius.com.au.

5. Which share registry manages Healius's stock?

Healius's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.